Skip to main content
Portfolio
TrendingElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive6AccountSocial
MARKETSINVESTLIVE6
Product
Kalshi ProInvestMarketsIncentive programSmall business hedgingInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQPrediction marketsFee scheduleTrading hoursRegulatoryTrust Center

© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
  1. Medicine

Will the FDA approve retatrutide?



AI Digest · FDA approval of Lilly's retatrutide before 2028 gains ground as regulator tightens GLP-1 eye warnings

Not advice · 8h ago

Kalshi traders favor the FDA approving drugmaker Eli Lilly's retatrutide before Jan 1, 2028, and that view gained ground this week. The FDA is making makers of GLP-1 drugs like Ozempic and Zepbound warn of a rare blinding eye condition, The Hill reports. The warning covers drugs already on the market, and the notice does not name retatrutide. Retatrutide is Lilly's experimental weight-loss drug, and the FDA has not yet approved it.

  • The Hill

    The GLP-1 blind spot: Why the FDA’s new eye stroke warning matters

Chance

72%
▲ 1

72%
▲ 1

91%

91%

89%

89%

2 more

Will the FDA approve retatrutide?

Before Jan 1, 2027

Odds
2% chance
Max payout
Dec 31, 2026
$0
Before Jul 1, 2028
91%
Before Jan 1, 2029
89%
Before Jan 1, 2028
72%
50%62.5%75%87.5%100%MayJunAugOctNov
$119,934 vol
More Science and Technology Markets

Trending Science and Technology markets

Best AI at the end of 2026?Will the U.S. confirm that aliens exist?Anthropic market share this weekOpen vs. Closed Token Volume (open weights share) in Nov 19, 2026Where will Waymo operate this year?Google market share this weekOpenRouter token usage in Nov 16–22, 2026OpenAI share of spend today (Vercel)

Science and Technology hub

All Science and Technology markets